In vitro and clinical characterization of the valved holding chamber AeroChamber Plus® Flow-Vu® for administrating tiotropium Respimat® in 1–5-year-old children with persistent asthmatic symptoms
When characterizing inhalation products, a comprehensive assessment including in vitro, pharmacokinetic (PK), and clinical data is required. We conducted a characterization of tiotropium Respimat® when administered with AeroChamber Plus® Flow-Vu® anti-static valved holding chamber (test VHC) with fa...
Ausführliche Beschreibung
Autor*in: |
Wachtel, Herbert [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2018 |
---|
Schlagwörter: |
---|
Umfang: |
10 |
---|
Übergeordnetes Werk: |
Enthalten in: Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report - Hung, Shuo-Wen ELSEVIER, 2021, Burlington, Mass |
---|---|
Übergeordnetes Werk: |
volume:137 ; year:2018 ; pages:181-190 ; extent:10 |
Links: |
---|
DOI / URN: |
10.1016/j.rmed.2018.03.010 |
---|
Katalog-ID: |
ELV04251889X |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV04251889X | ||
003 | DE-627 | ||
005 | 20230624095959.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180726s2018 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.rmed.2018.03.010 |2 doi | |
028 | 5 | 2 | |a GBV00000000000181A.pica |
035 | |a (DE-627)ELV04251889X | ||
035 | |a (ELSEVIER)S0954-6111(18)30074-X | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 610 | |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 610 |q VZ |
084 | |a 44.52 |2 bkl | ||
100 | 1 | |a Wachtel, Herbert |e verfasserin |4 aut | |
245 | 1 | 0 | |a In vitro and clinical characterization of the valved holding chamber AeroChamber Plus® Flow-Vu® for administrating tiotropium Respimat® in 1–5-year-old children with persistent asthmatic symptoms |
264 | 1 | |c 2018 | |
300 | |a 10 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a When characterizing inhalation products, a comprehensive assessment including in vitro, pharmacokinetic (PK), and clinical data is required. We conducted a characterization of tiotropium Respimat® when administered with AeroChamber Plus® Flow-Vu® anti-static valved holding chamber (test VHC) with face mask in 1–5-year-olds with persistent asthmatic symptoms. | ||
650 | 7 | |a VHC |2 Elsevier | |
650 | 7 | |a AeroChamber Plus® Flow-Vu® |2 Elsevier | |
650 | 7 | |a Respimat® Soft Mist™ Inhaler |2 Elsevier | |
650 | 7 | |a Children |2 Elsevier | |
650 | 7 | |a Fine particle fraction |2 Elsevier | |
650 | 7 | |a Asthma |2 Elsevier | |
700 | 1 | |a Nagel, Mark |4 oth | |
700 | 1 | |a Engel, Michael |4 oth | |
700 | 1 | |a El Azzi, Georges |4 oth | |
700 | 1 | |a Sharma, Ashish |4 oth | |
700 | 1 | |a Suggett, Jason |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Harcourt |a Hung, Shuo-Wen ELSEVIER |t Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report |d 2021 |g Burlington, Mass |w (DE-627)ELV009124330 |
773 | 1 | 8 | |g volume:137 |g year:2018 |g pages:181-190 |g extent:10 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.rmed.2018.03.010 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
936 | b | k | |a 44.52 |j Therapie |x Medizin |q VZ |
951 | |a AR | ||
952 | |d 137 |j 2018 |h 181-190 |g 10 | ||
953 | |2 045F |a 610 |
author_variant |
h w hw |
---|---|
matchkey_str |
wachtelherbertnagelmarkengelmichaelelazz:2018----:niradlnclhrceiainfhvlehlighmearcabrlslwuoamnsrtntorpursiai1ya |
hierarchy_sort_str |
2018 |
bklnumber |
44.52 |
publishDate |
2018 |
allfields |
10.1016/j.rmed.2018.03.010 doi GBV00000000000181A.pica (DE-627)ELV04251889X (ELSEVIER)S0954-6111(18)30074-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.52 bkl Wachtel, Herbert verfasserin aut In vitro and clinical characterization of the valved holding chamber AeroChamber Plus® Flow-Vu® for administrating tiotropium Respimat® in 1–5-year-old children with persistent asthmatic symptoms 2018 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier When characterizing inhalation products, a comprehensive assessment including in vitro, pharmacokinetic (PK), and clinical data is required. We conducted a characterization of tiotropium Respimat® when administered with AeroChamber Plus® Flow-Vu® anti-static valved holding chamber (test VHC) with face mask in 1–5-year-olds with persistent asthmatic symptoms. VHC Elsevier AeroChamber Plus® Flow-Vu® Elsevier Respimat® Soft Mist™ Inhaler Elsevier Children Elsevier Fine particle fraction Elsevier Asthma Elsevier Nagel, Mark oth Engel, Michael oth El Azzi, Georges oth Sharma, Ashish oth Suggett, Jason oth Enthalten in Harcourt Hung, Shuo-Wen ELSEVIER Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report 2021 Burlington, Mass (DE-627)ELV009124330 volume:137 year:2018 pages:181-190 extent:10 https://doi.org/10.1016/j.rmed.2018.03.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.52 Therapie Medizin VZ AR 137 2018 181-190 10 045F 610 |
spelling |
10.1016/j.rmed.2018.03.010 doi GBV00000000000181A.pica (DE-627)ELV04251889X (ELSEVIER)S0954-6111(18)30074-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.52 bkl Wachtel, Herbert verfasserin aut In vitro and clinical characterization of the valved holding chamber AeroChamber Plus® Flow-Vu® for administrating tiotropium Respimat® in 1–5-year-old children with persistent asthmatic symptoms 2018 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier When characterizing inhalation products, a comprehensive assessment including in vitro, pharmacokinetic (PK), and clinical data is required. We conducted a characterization of tiotropium Respimat® when administered with AeroChamber Plus® Flow-Vu® anti-static valved holding chamber (test VHC) with face mask in 1–5-year-olds with persistent asthmatic symptoms. VHC Elsevier AeroChamber Plus® Flow-Vu® Elsevier Respimat® Soft Mist™ Inhaler Elsevier Children Elsevier Fine particle fraction Elsevier Asthma Elsevier Nagel, Mark oth Engel, Michael oth El Azzi, Georges oth Sharma, Ashish oth Suggett, Jason oth Enthalten in Harcourt Hung, Shuo-Wen ELSEVIER Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report 2021 Burlington, Mass (DE-627)ELV009124330 volume:137 year:2018 pages:181-190 extent:10 https://doi.org/10.1016/j.rmed.2018.03.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.52 Therapie Medizin VZ AR 137 2018 181-190 10 045F 610 |
allfields_unstemmed |
10.1016/j.rmed.2018.03.010 doi GBV00000000000181A.pica (DE-627)ELV04251889X (ELSEVIER)S0954-6111(18)30074-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.52 bkl Wachtel, Herbert verfasserin aut In vitro and clinical characterization of the valved holding chamber AeroChamber Plus® Flow-Vu® for administrating tiotropium Respimat® in 1–5-year-old children with persistent asthmatic symptoms 2018 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier When characterizing inhalation products, a comprehensive assessment including in vitro, pharmacokinetic (PK), and clinical data is required. We conducted a characterization of tiotropium Respimat® when administered with AeroChamber Plus® Flow-Vu® anti-static valved holding chamber (test VHC) with face mask in 1–5-year-olds with persistent asthmatic symptoms. VHC Elsevier AeroChamber Plus® Flow-Vu® Elsevier Respimat® Soft Mist™ Inhaler Elsevier Children Elsevier Fine particle fraction Elsevier Asthma Elsevier Nagel, Mark oth Engel, Michael oth El Azzi, Georges oth Sharma, Ashish oth Suggett, Jason oth Enthalten in Harcourt Hung, Shuo-Wen ELSEVIER Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report 2021 Burlington, Mass (DE-627)ELV009124330 volume:137 year:2018 pages:181-190 extent:10 https://doi.org/10.1016/j.rmed.2018.03.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.52 Therapie Medizin VZ AR 137 2018 181-190 10 045F 610 |
allfieldsGer |
10.1016/j.rmed.2018.03.010 doi GBV00000000000181A.pica (DE-627)ELV04251889X (ELSEVIER)S0954-6111(18)30074-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.52 bkl Wachtel, Herbert verfasserin aut In vitro and clinical characterization of the valved holding chamber AeroChamber Plus® Flow-Vu® for administrating tiotropium Respimat® in 1–5-year-old children with persistent asthmatic symptoms 2018 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier When characterizing inhalation products, a comprehensive assessment including in vitro, pharmacokinetic (PK), and clinical data is required. We conducted a characterization of tiotropium Respimat® when administered with AeroChamber Plus® Flow-Vu® anti-static valved holding chamber (test VHC) with face mask in 1–5-year-olds with persistent asthmatic symptoms. VHC Elsevier AeroChamber Plus® Flow-Vu® Elsevier Respimat® Soft Mist™ Inhaler Elsevier Children Elsevier Fine particle fraction Elsevier Asthma Elsevier Nagel, Mark oth Engel, Michael oth El Azzi, Georges oth Sharma, Ashish oth Suggett, Jason oth Enthalten in Harcourt Hung, Shuo-Wen ELSEVIER Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report 2021 Burlington, Mass (DE-627)ELV009124330 volume:137 year:2018 pages:181-190 extent:10 https://doi.org/10.1016/j.rmed.2018.03.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.52 Therapie Medizin VZ AR 137 2018 181-190 10 045F 610 |
allfieldsSound |
10.1016/j.rmed.2018.03.010 doi GBV00000000000181A.pica (DE-627)ELV04251889X (ELSEVIER)S0954-6111(18)30074-X DE-627 ger DE-627 rakwb eng 610 610 DE-600 610 VZ 44.52 bkl Wachtel, Herbert verfasserin aut In vitro and clinical characterization of the valved holding chamber AeroChamber Plus® Flow-Vu® for administrating tiotropium Respimat® in 1–5-year-old children with persistent asthmatic symptoms 2018 10 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier When characterizing inhalation products, a comprehensive assessment including in vitro, pharmacokinetic (PK), and clinical data is required. We conducted a characterization of tiotropium Respimat® when administered with AeroChamber Plus® Flow-Vu® anti-static valved holding chamber (test VHC) with face mask in 1–5-year-olds with persistent asthmatic symptoms. VHC Elsevier AeroChamber Plus® Flow-Vu® Elsevier Respimat® Soft Mist™ Inhaler Elsevier Children Elsevier Fine particle fraction Elsevier Asthma Elsevier Nagel, Mark oth Engel, Michael oth El Azzi, Georges oth Sharma, Ashish oth Suggett, Jason oth Enthalten in Harcourt Hung, Shuo-Wen ELSEVIER Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report 2021 Burlington, Mass (DE-627)ELV009124330 volume:137 year:2018 pages:181-190 extent:10 https://doi.org/10.1016/j.rmed.2018.03.010 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA 44.52 Therapie Medizin VZ AR 137 2018 181-190 10 045F 610 |
language |
English |
source |
Enthalten in Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report Burlington, Mass volume:137 year:2018 pages:181-190 extent:10 |
sourceStr |
Enthalten in Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report Burlington, Mass volume:137 year:2018 pages:181-190 extent:10 |
format_phy_str_mv |
Article |
bklname |
Therapie |
institution |
findex.gbv.de |
topic_facet |
VHC AeroChamber Plus® Flow-Vu® Respimat® Soft Mist™ Inhaler Children Fine particle fraction Asthma |
dewey-raw |
610 |
isfreeaccess_bool |
false |
container_title |
Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report |
authorswithroles_txt_mv |
Wachtel, Herbert @@aut@@ Nagel, Mark @@oth@@ Engel, Michael @@oth@@ El Azzi, Georges @@oth@@ Sharma, Ashish @@oth@@ Suggett, Jason @@oth@@ |
publishDateDaySort_date |
2018-01-01T00:00:00Z |
hierarchy_top_id |
ELV009124330 |
dewey-sort |
3610 |
id |
ELV04251889X |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV04251889X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624095959.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.rmed.2018.03.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000181A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV04251889X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0954-6111(18)30074-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Wachtel, Herbert</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">In vitro and clinical characterization of the valved holding chamber AeroChamber Plus® Flow-Vu® for administrating tiotropium Respimat® in 1–5-year-old children with persistent asthmatic symptoms</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">When characterizing inhalation products, a comprehensive assessment including in vitro, pharmacokinetic (PK), and clinical data is required. We conducted a characterization of tiotropium Respimat® when administered with AeroChamber Plus® Flow-Vu® anti-static valved holding chamber (test VHC) with face mask in 1–5-year-olds with persistent asthmatic symptoms.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">VHC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AeroChamber Plus® Flow-Vu®</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Respimat® Soft Mist™ Inhaler</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Children</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Fine particle fraction</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Asthma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nagel, Mark</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Engel, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">El Azzi, Georges</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sharma, Ashish</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Suggett, Jason</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Harcourt</subfield><subfield code="a">Hung, Shuo-Wen ELSEVIER</subfield><subfield code="t">Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report</subfield><subfield code="d">2021</subfield><subfield code="g">Burlington, Mass</subfield><subfield code="w">(DE-627)ELV009124330</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:137</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:181-190</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.rmed.2018.03.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.52</subfield><subfield code="j">Therapie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">137</subfield><subfield code="j">2018</subfield><subfield code="h">181-190</subfield><subfield code="g">10</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
author |
Wachtel, Herbert |
spellingShingle |
Wachtel, Herbert ddc 610 bkl 44.52 Elsevier VHC Elsevier AeroChamber Plus® Flow-Vu® Elsevier Respimat® Soft Mist™ Inhaler Elsevier Children Elsevier Fine particle fraction Elsevier Asthma In vitro and clinical characterization of the valved holding chamber AeroChamber Plus® Flow-Vu® for administrating tiotropium Respimat® in 1–5-year-old children with persistent asthmatic symptoms |
authorStr |
Wachtel, Herbert |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV009124330 |
format |
electronic Article |
dewey-ones |
610 - Medicine & health |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
610 610 DE-600 610 VZ 44.52 bkl In vitro and clinical characterization of the valved holding chamber AeroChamber Plus® Flow-Vu® for administrating tiotropium Respimat® in 1–5-year-old children with persistent asthmatic symptoms VHC Elsevier AeroChamber Plus® Flow-Vu® Elsevier Respimat® Soft Mist™ Inhaler Elsevier Children Elsevier Fine particle fraction Elsevier Asthma Elsevier |
topic |
ddc 610 bkl 44.52 Elsevier VHC Elsevier AeroChamber Plus® Flow-Vu® Elsevier Respimat® Soft Mist™ Inhaler Elsevier Children Elsevier Fine particle fraction Elsevier Asthma |
topic_unstemmed |
ddc 610 bkl 44.52 Elsevier VHC Elsevier AeroChamber Plus® Flow-Vu® Elsevier Respimat® Soft Mist™ Inhaler Elsevier Children Elsevier Fine particle fraction Elsevier Asthma |
topic_browse |
ddc 610 bkl 44.52 Elsevier VHC Elsevier AeroChamber Plus® Flow-Vu® Elsevier Respimat® Soft Mist™ Inhaler Elsevier Children Elsevier Fine particle fraction Elsevier Asthma |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
m n mn m e me a g e ag age a s as j s js |
hierarchy_parent_title |
Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report |
hierarchy_parent_id |
ELV009124330 |
dewey-tens |
610 - Medicine & health |
hierarchy_top_title |
Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV009124330 |
title |
In vitro and clinical characterization of the valved holding chamber AeroChamber Plus® Flow-Vu® for administrating tiotropium Respimat® in 1–5-year-old children with persistent asthmatic symptoms |
ctrlnum |
(DE-627)ELV04251889X (ELSEVIER)S0954-6111(18)30074-X |
title_full |
In vitro and clinical characterization of the valved holding chamber AeroChamber Plus® Flow-Vu® for administrating tiotropium Respimat® in 1–5-year-old children with persistent asthmatic symptoms |
author_sort |
Wachtel, Herbert |
journal |
Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report |
journalStr |
Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
600 - Technology |
recordtype |
marc |
publishDateSort |
2018 |
contenttype_str_mv |
zzz |
container_start_page |
181 |
author_browse |
Wachtel, Herbert |
container_volume |
137 |
physical |
10 |
class |
610 610 DE-600 610 VZ 44.52 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
Wachtel, Herbert |
doi_str_mv |
10.1016/j.rmed.2018.03.010 |
dewey-full |
610 |
title_sort |
in vitro and clinical characterization of the valved holding chamber aerochamber plus® flow-vu® for administrating tiotropium respimat® in 1–5-year-old children with persistent asthmatic symptoms |
title_auth |
In vitro and clinical characterization of the valved holding chamber AeroChamber Plus® Flow-Vu® for administrating tiotropium Respimat® in 1–5-year-old children with persistent asthmatic symptoms |
abstract |
When characterizing inhalation products, a comprehensive assessment including in vitro, pharmacokinetic (PK), and clinical data is required. We conducted a characterization of tiotropium Respimat® when administered with AeroChamber Plus® Flow-Vu® anti-static valved holding chamber (test VHC) with face mask in 1–5-year-olds with persistent asthmatic symptoms. |
abstractGer |
When characterizing inhalation products, a comprehensive assessment including in vitro, pharmacokinetic (PK), and clinical data is required. We conducted a characterization of tiotropium Respimat® when administered with AeroChamber Plus® Flow-Vu® anti-static valved holding chamber (test VHC) with face mask in 1–5-year-olds with persistent asthmatic symptoms. |
abstract_unstemmed |
When characterizing inhalation products, a comprehensive assessment including in vitro, pharmacokinetic (PK), and clinical data is required. We conducted a characterization of tiotropium Respimat® when administered with AeroChamber Plus® Flow-Vu® anti-static valved holding chamber (test VHC) with face mask in 1–5-year-olds with persistent asthmatic symptoms. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA |
title_short |
In vitro and clinical characterization of the valved holding chamber AeroChamber Plus® Flow-Vu® for administrating tiotropium Respimat® in 1–5-year-old children with persistent asthmatic symptoms |
url |
https://doi.org/10.1016/j.rmed.2018.03.010 |
remote_bool |
true |
author2 |
Nagel, Mark Engel, Michael El Azzi, Georges Sharma, Ashish Suggett, Jason |
author2Str |
Nagel, Mark Engel, Michael El Azzi, Georges Sharma, Ashish Suggett, Jason |
ppnlink |
ELV009124330 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth |
doi_str |
10.1016/j.rmed.2018.03.010 |
up_date |
2024-07-06T23:00:49.727Z |
_version_ |
1803872475261435904 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV04251889X</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230624095959.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180726s2018 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.rmed.2018.03.010</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBV00000000000181A.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV04251889X</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0954-6111(18)30074-X</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">44.52</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Wachtel, Herbert</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">In vitro and clinical characterization of the valved holding chamber AeroChamber Plus® Flow-Vu® for administrating tiotropium Respimat® in 1–5-year-old children with persistent asthmatic symptoms</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2018</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">10</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">When characterizing inhalation products, a comprehensive assessment including in vitro, pharmacokinetic (PK), and clinical data is required. We conducted a characterization of tiotropium Respimat® when administered with AeroChamber Plus® Flow-Vu® anti-static valved holding chamber (test VHC) with face mask in 1–5-year-olds with persistent asthmatic symptoms.</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">VHC</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">AeroChamber Plus® Flow-Vu®</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Respimat® Soft Mist™ Inhaler</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Children</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Fine particle fraction</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Asthma</subfield><subfield code="2">Elsevier</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Nagel, Mark</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Engel, Michael</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">El Azzi, Georges</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Sharma, Ashish</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Suggett, Jason</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Harcourt</subfield><subfield code="a">Hung, Shuo-Wen ELSEVIER</subfield><subfield code="t">Integrated Chinese herbal medicine and Western medicine successfully resolves spontaneous subcutaneous emphysema and pneumomediastinum in a patient with severe COVID-19 in Taiwan: A case report</subfield><subfield code="d">2021</subfield><subfield code="g">Burlington, Mass</subfield><subfield code="w">(DE-627)ELV009124330</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:137</subfield><subfield code="g">year:2018</subfield><subfield code="g">pages:181-190</subfield><subfield code="g">extent:10</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.rmed.2018.03.010</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">44.52</subfield><subfield code="j">Therapie</subfield><subfield code="x">Medizin</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">137</subfield><subfield code="j">2018</subfield><subfield code="h">181-190</subfield><subfield code="g">10</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">610</subfield></datafield></record></collection>
|
score |
7.39985 |